{'52WeekChange': 0.3293885,
 'SandP52WeekChange': 0.0644362,
 'address1': '2600 Via Fortuna',
 'address2': 'Suite 360',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 7.3,
 'askSize': 800,
 'averageDailyVolume10Day': 195112,
 'averageVolume': 126534,
 'averageVolume10days': 195112,
 'beta': None,
 'beta3Year': None,
 'bid': 6.74,
 'bidSize': 800,
 'bookValue': -2.71,
 'category': None,
 'circulatingSupply': None,
 'city': 'Austin',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 7.08,
 'dayLow': 6.74,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': None,
 'enterpriseToRevenue': None,
 'enterpriseValue': 100115968,
 'exDividendDate': None,
 'exchange': 'NCM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 6.0304284,
 'fiftyTwoWeekHigh': 7.5,
 'fiftyTwoWeekLow': 3.44,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 11791339,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fullTimeEmployees': 4,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.22049,
 'heldPercentInstitutions': 0.05479,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/tffpharma.com',
 'longBusinessSummary': 'TFF Pharmaceuticals, Inc., an early-stage '
                        'biopharmaceutical company, focuses on developing and '
                        'commercializing drug products based on its patented '
                        'Thin Film Freezing, or TFF, technology platform. It '
                        'intends to initially focus on the development of '
                        'inhaled dry powder drugs for the treatment of '
                        'pulmonary diseases and conditions. The company has a '
                        'research collaboration with the University of '
                        "Georgia's Center for Vaccines and Immunology (CVI), "
                        'along with the University of Texas at Austin (UT '
                        'Austin), to evaluate the immunogenicity of universal '
                        'influenza vaccines; and cooperative research and '
                        'development agreement with United States Army Medical '
                        'Research Institute of Infectious Diseases for use of '
                        'its thin film freezing technology platform. TFF '
                        'Pharmaceuticals, Inc. was founded in 2018 and is '
                        'based in Austin, Texas.',
 'longName': 'TFF Pharmaceuticals, Inc.',
 'market': 'us_market',
 'marketCap': 125847256,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_557389546',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -38068444,
 'nextFiscalYearEnd': 1640908800,
 'open': 7,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '737 802 1973',
 'previousClose': 7,
 'priceHint': 2,
 'priceToBook': None,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 7.08,
 'regularMarketDayLow': 6.74,
 'regularMarketOpen': 7,
 'regularMarketPreviousClose': 7,
 'regularMarketPrice': 7,
 'regularMarketVolume': 61801,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 18671700,
 'sharesPercentSharesOut': 0.0028,
 'sharesShort': 52365,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 53096,
 'shortName': 'TFF Pharmaceuticals, Inc.',
 'shortPercentOfFloat': 0.004,
 'shortRatio': 0.49,
 'startDate': None,
 'state': 'TX',
 'strikePrice': None,
 'symbol': 'TFFP',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -2.604,
 'twoHundredDayAverage': 5.0962086,
 'volume': 61801,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.tffpharma.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '78746'}